ArticleInternal medicine (Tokyo, Japan)2018

Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma.

Tokuhiro Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.